-transparent.png){kind=logo}
A double-blind comparative trial of loxapine and trifluoperazine was carried out in 57 acute and chronic schizophrenic patients. In both groups of patients loxapine proved to be equivalent in its effects to trifluoperazine and there were suggestions it might be rather more effective in chronic patients. Side-effects were similar with the two drugs but anticholinergic effects, excitement, dizziness and faintness occurred rather more commonly with loxapine. Laboratory tests, urine analysis, cardiovascular and ophthalmological investigations showed no significant abnormalities.
Related Publications
L G Kiloh, and
S E Williams, and
D A Grant, and
P S Whetton
June 1975,
Diseases of the nervous system,
L G Kiloh, and
S E Williams, and
D A Grant, and
P S Whetton
January 1976,
Journal of clinical pharmacology,
L G Kiloh, and
S E Williams, and
D A Grant, and
P S Whetton
January 1973,
Current therapeutic research, clinical and experimental,
L G Kiloh, and
S E Williams, and
D A Grant, and
P S Whetton
September 1969,
Comprehensive psychiatry,
L G Kiloh, and
S E Williams, and
D A Grant, and
P S Whetton
April 1976,
Psychopharmacology bulletin,
L G Kiloh, and
S E Williams, and
D A Grant, and
P S Whetton
November 1972,
Current therapeutic research, clinical and experimental,
L G Kiloh, and
S E Williams, and
D A Grant, and
P S Whetton
October 1968,
Current therapeutic research, clinical and experimental,
L G Kiloh, and
S E Williams, and
D A Grant, and
P S Whetton
March 1967,
Diseases of the nervous system,
L G Kiloh, and
S E Williams, and
D A Grant, and
P S Whetton
January 1968,
Diseases of the nervous system,
L G Kiloh, and
S E Williams, and
D A Grant, and
P S Whetton
September 1974,
Current therapeutic research, clinical and experimental,
